Invermectin is a medication that has been widely used in the treatment of several medical conditions, including river blindness and onchocerciasis. It is produced by Merck, a leading pharmaceutical company.
Merck has stated that invermectin is the most important drug currently used in control programs and represents approximately 80% of the total market. The medication, which is used to treat river blindness and onchocerciasis, has been recommended by the 2018 data according to data presented by the 2018 data. Additionally, the market for ivermectin according to the 2017 data is $384 million according to data from the 2008 data. In 2018, 768 tons of ivermectin were sold in China, according to data from the 2018 data.
There are currently 18 companies in China that produce 227 types of generic drugs, which includes ivermectin. The domestic production volume of 71 tons of ivermectin in 2019 is expected to reach 100 tons according to forecast data from 2019. This is nearly double the amount produced in 2018.
It should be noted that these figures represent the sales and production data for ivermectin in China and may vary depending on the specific context and location.
merck 2230-1
